Nitric oxide and cyclic GMP in cell signaling and drug development

New England Journal of Medicine

Volumn 355, Issue 19, 2006, Pages 2003-2011

  Murad, Ferid ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERYL TRINITRATE; GUANOSINE TRIPHOSPHATE; GUANYLATE CYCLASE; HEMOGLOBIN; HYDROXYLAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYOGLOBIN; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM AZIDE; SODIUM NITRITE; VASODILATOR AGENT; ISOPROTEIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE RELAXATION; VASODILATATION; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

CYCLIC GMP; DRUG DESIGN; GUANYLATE CYCLASE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33750689471     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa063904     Document Type: Article

References (39)

1. Rall TW, Sutherland EW. Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 1958;232:1065-76.
2. Murad F, Chi YM, Rall TW, Sutherland EW. Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3′,5′-phosphate by preparations from cardiac muscle and liver. J Biol Chem 1962;237:1233-8.
3. Ashman DF, Lipton R, Melicow MM, Price TD. Isolation of adenosine 3′, 5′-monophosphate and guanosine 3′, 5′-monophosphate from rat urine. Biochem Biophys Res Commun 1963;11:330-4.
4. Murad F. Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci Rep 1999;19:133-54.
5. Kimura H, Murad F. Evidence for two different forms of guanylate cyclase in rat heart. J Biol Chem 1974;249:6910-6.
6. Kimura H, Murad F. Idem. Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation. Metabolism 1975;24:439-45.
7. Kimura H, Mittal CK, Murad F. Activation of guanylate cyclase from rat liver and other tissues with sodium azide. J Biol Chem 1975;250:8016-22.
8. Murad F, Mittal CK, Arnold WP, Katsuki S, Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 1978;9:145-58.
9. Mittal CK, Kimura H, Murad F. Purification and properties of a protein required for sodium azide activation of guanylate cyclase. J Biol Chem 1977;252:4384-90.
10. Kimura H, Mittal CK, Murad F. Increases in cyclic GMP levels in brain and liver with sodium azide an activator of guanylate cyclase. Nature 1975;257:700-2.
11. Katsuki S, Arnold WP, Murad F. Effect of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucleotide Res 1977;3:239-47.
12. Katsuki S, Arnold WP, Mittal CK, Murad F. Stimulation of formation and accumulation of cyclic GMP by smooth muscle relaxing agents. In: Proceedings of the 2nd Japanese Cyclic Nucleotide Conference, Osaka, Japan, July 7-9, 1977:44-50.
13. Murad F, Mittal CK, Arnold WP, Braughler JM. Effect of nitro-compound smooth muscle relaxants and other materials on cyclic GMP metabolism. In: Boissier JR, Lechat P, Fichelle J, eds. Advances in pharmacology and therapeutics. New York: Pergamon Press, 1978:123-32.
14. Murad F. Cyclic GMP synthesis, metabolism and function: introduction and some historical comments. Adv Pharmacol 1994;26:1-5.
15. Katsuki S, Arnold W, Mittal CK, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977;3:23-35.
16. Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 1977;74:3203-7.
17. Arnold WP, Aldred R, Murad F. Cigarette smoke activates guanylate cyclase and increases guanosine 3′,5′-monophosphate in tissues. Science 1977;198:934-6.
18. Furchgott RF, Zarwadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature 1980;288:373-6.
19. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J Clin Invest 1986;78:1-5.
20. Rapoport RM, Murad F. Agonist-induced endothelial-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 1983;52:352-7.
21. Rapoport RM, Murad F. Idem. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role for cyclic GMP. J Cyclic Nucleotide Protein Phosphor Res 1983;9:281-96.
22. Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 1983;306:174-6.
23. Fiscus RR, Rapoport RM, Murad F. Endothelium-dependent and nitrovasodilator-induced activation of cyclic GMP-dependent protein kinase in rat aorta. J Cyclic Nucleotide Protein Phosphor Res 1983-1984;9:415-25.
24. Furchgott R. Studies on relaxation of rabbit aorta by sodium nitrite. In: Vanhoutte PM, ed. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. New York: Raven Press, 1988:401-14.
25. Ignarro L, Burns R, Wood K. Biochemical and pharmacological properties of EDRF and its similarity to nitric oxide. In: Vanhoutte PM, ed. Vasodilatation: vascular smooth muscle, peptides, autonomic nerves, and endothelium. New York: Raven Press, 1988:427-35.
26. Murad F. Modulation of the guanylate cyclase-cGMP system by vasodilators and the role of free radicals as second messengers. In: Catravas JD, Callow AD, Ryan US, eds. Vascular endothelium: pharmacologic and genetic manipulations. New York: Plenum Press, 1998:157-64.
27. Deguchi T, Yoshioko M. L-arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J Biol Chem 1982;257:10147-51.
28. Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen activation to nitrite. Science 1987;235:473-6.
29. Kamisaki Y, Saheki S, Nakane M, et al. Soluble guanylate cyclase from rat lung exists as a heterodimer. J Biol Chem 1986;261:7236-41.
30. Sharina IG, Krumenacker JS, Martin E, Murad F. Genomic organization of alpha 1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes. Proc Natl Acad Sci U S A 2000;97:10878-83.
31. Krumenacker JS, Hyder SM, Murad F. Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. Proc Natl Acad Sci U S A 2001;98:717-22.
32. Krumenacker JS, Katsuki J, Kots A, Murad F. Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocyte precursors. Nitric Oxide 2006;14:1-11.
33. Martin E, Berka V, Tsai AL, Murad F. Soluble guanylyl cyclase: the nitric oxide receptor. Methods Enzymol 2005;396:478-92.
34. Kuno T, Andresen JW, Kamisaki Y, et al. Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J Biol Chem 1986;261:5817-23.
35. Garbers DL. Guanylyl cyclase-linked receptors. Pharmacol Ther 1991;50:337-45.
36. Mittal CK, Murad F. Formation of aden osine 3′:5′- monophosphate by preparations of guanylate cyclase from rat liver and other tissues. J Biol Chem 1977;252:3136-40.
37. Mittal CK, Braughler JM, Ichihara K, Murad F. Synthesis of adenosine 3′,5′-monophosphate by guanylate cyclase, a new pathway for its formation. Biochim Biophys Acta 1979;585:333-42.
38. Butcher RW, Sutherland EW. Adenosine 3′,5′-monophosphate in biological materials. I. Purification and properties of cyclic 3′,5′-nucleotice phosphodiesterase and use of this enzyme to character adenosine 3′,5′-phosphate in human urine. J Biol Chem 1962;237:1244-50.
39. Beavo JA. Cyclic nucleotide phosphodiesterases; functional implications of multiple isoforms. Physiol Rev 1995;75:725-48.